XRCC1 and central nervous system cancer: The first study on the association between XRCC1 Arg194Trp polymorphism and glioma risk was performed by Liu et al in 2007 [36], involving 756 cases and 754 controls from Chinese, and the results indicated no significant association between XRCC1 Arg194Trp polymorphisms and glioma risk.